Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08953_nanopub.RAbS-siphfdtCdeM-zJ9u1YXY01jTXezmesl_h-t-nzb4#assertion>. }
Showing items 1 to 13 of
13
with 100 items per page.
- drugbank:DB08953 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08953 label "Indalpine [drugbank:DB08953]" assertion.
- drugbank:DB08953 seeAlso DB08953 assertion.
- drugbank:DB08953 description "Indalpine was one of the first selective serotonin reuptake inhibitors to reach the American market. It was initially marketed by Pharmuka. However, after the emergence of widespread concern regarding adverse effects caused by SSRIs, and reported hematological effects caused by Indalpine, it was abruptly withdrawn from the US market." assertion.
- drugbank:DB08953 identifier "drugbank:DB08953" assertion.
- drugbank:DB08953 title "Indalpine" assertion.
- drugbank:DB08953 drugbank_vocabulary:x-cas cas:63758-79-2 assertion.
- drugbank:DB08953 drugbank_vocabulary:drugbank-id "DB08953" assertion.
- drugbank:DB08953 bio2rdf_vocabulary:x-identifiers.org DB08953 assertion.
- drugbank:DB08953 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08953" assertion.
- drugbank:DB08953 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08953 bio2rdf_vocabulary:identifier "DB08953" assertion.
- drugbank:DB08953 drugbank_vocabulary:x-wikipedia wikipedia:Indalpine assertion.